The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
State of the Facilities Management Industry in 2025
City of Hope to Open New Cancer Specialty Hospital in California
Montefiore Einstein Opening New Inpatient Center for Youth in the Bronx
Skill Stacking: How Micro-Credentials Are Reshaping Trades
Prima Medicine Opens New Location in Tysons, Virginia